Open AccessExosomes released by imatinib‑resistant K562 cells contain specific membrane markers, IFITM3, CD146 and CD36 and increase the survival of imatinib‑sensitive cells in the presence of imatinib
Author(s) -
Tereza Hrdinova,
Ondřej Toman,
Jiří Dresler,
Jana Klimentová,
Barbora Šalovská,
Petr Pajer,
Oldřich Bartoš,
Václava Polívková,
Jana Linhartová,
Kateřina Machová Poláková,
Hana Kabíčková,
Barbora Brodská,
Matyáš Krijt,
J Živný,
Daniel Vyoral,
Jir̆ı́ Petrák
Publication year - 2020
Publication title -
international journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.405
H-Index - 122
ISSN - 1019-6439
DOI - 10.3892/ijo.2020.5163
Subject(s) - microvesicles , imatinib , biology , cancer research , myeloid leukemia , tyrosine kinase , k562 cells , imatinib mesylate , exosome , oncogene , cancer , immunology , microbiology and biotechnology , leukemia , cell cycle , microrna , signal transduction , biochemistry , genetics , gene